Douglas Unwin
Chief Executive Officer at GEOLOGICA RESOURCE CORP.
Net worth: 58 352 $ as of 30/05/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marc Branson | M | 47 | 3 years | |
| Kyle Appleby | M | 48 | 2 years | |
| R. Bustin | M | - |
University of British Columbia
| 47 years |
| Robert Charlton | M | 65 | 8 years | |
| David Shisel | M | 37 | 1 years | |
| Raymond J. Andersen | M | 76 |
University of British Columbia
| 47 years |
| Andrew Saltis | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Derick Sinclair | M | 68 |
Pacific Therapeutics Ltd.
 Pacific Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Pacific Therapeutics Ltd. is a clinical stage specialty pharmaceutical company. It focuses on the identification and development of drug candidates suitable for reformulation and repurposing. The company's drug candidates are used to treat diseases of the liver and lungs caused by excessive and progressive tissue scarring, called fibrosis. Pacific Therapeutics was founded by Douglas H. Unwin on September 12, 2005 and is headquartered in Vancouver, Canada. | 6 years |
| Ian Mallmann | M | 63 |
University of British Columbia
| 11 years |
| Cheung Hoi Yu | M | 69 |
University of Saskatchewan
| 12 years |
| Douglas Wallis | M | - |
Pacific Therapeutics Ltd.
Pacific Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Pacific Therapeutics Ltd. is a clinical stage specialty pharmaceutical company. It focuses on the identification and development of drug candidates suitable for reformulation and repurposing. The company's drug candidates are used to treat diseases of the liver and lungs caused by excessive and progressive tissue scarring, called fibrosis. Pacific Therapeutics was founded by Douglas H. Unwin on September 12, 2005 and is headquartered in Vancouver, Canada. | 4 years |
| Kathy Agnes Leavens | F | - |
University of British Columbia
| 6 years |
| David de Witt | M | 71 |
University of British Columbia
| 7 years |
| Mary Garden | F | 65 |
University of British Columbia
| 6 years |
| W. White | M | 68 |
University of British Columbia
| 6 years |
| John Cumming | M | 73 |
University of British Columbia
| 7 years |
| Blair E. Ripplinger | M | - |
University of British Columbia
| 8 years |
| Keenan Hohol | M | 59 | 3 years | |
| Dow Peter Famulak | M | 64 |
University of Saskatchewan
University of British Columbia
| 8 years |
| Kenneth R. Burgess | M | - |
University of British Columbia
| 5 years |
| Robert W. R. Bishop | M | - |
University of British Columbia
| 7 years |
| Jack H. L. Miller | M | - |
University of British Columbia
| 6 years |
| David Nairne | M | - |
University of British Columbia
| 5 years |
| Mark van der Horst | M | 58 | 2 years | |
| Corey Michael Dean | M | - |
University of British Columbia
| 5 years |
| Martin MacLachlan | M | - |
University of British Columbia
| 5 years |
| Brian Gusko | M | 57 |
Pacific Therapeutics Ltd.
Pacific Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Pacific Therapeutics Ltd. is a clinical stage specialty pharmaceutical company. It focuses on the identification and development of drug candidates suitable for reformulation and repurposing. The company's drug candidates are used to treat diseases of the liver and lungs caused by excessive and progressive tissue scarring, called fibrosis. Pacific Therapeutics was founded by Douglas H. Unwin on September 12, 2005 and is headquartered in Vancouver, Canada. | - |
| Sean Quinn | M | - |
University of Saskatchewan
| 7 years |
| Michael Edward O'Connor | M | - |
University of British Columbia
| 4 years |
| John E. Stonier | M | - |
University of British Columbia
| 8 years |
| Wendi V. Rodrigueza | M | 58 |
Pacific Therapeutics Ltd.
Pacific Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Pacific Therapeutics Ltd. is a clinical stage specialty pharmaceutical company. It focuses on the identification and development of drug candidates suitable for reformulation and repurposing. The company's drug candidates are used to treat diseases of the liver and lungs caused by excessive and progressive tissue scarring, called fibrosis. Pacific Therapeutics was founded by Douglas H. Unwin on September 12, 2005 and is headquartered in Vancouver, Canada. | 6 years |
| M Greg Beniston | M | 63 |
Pacific Therapeutics Ltd.
Pacific Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Pacific Therapeutics Ltd. is a clinical stage specialty pharmaceutical company. It focuses on the identification and development of drug candidates suitable for reformulation and repurposing. The company's drug candidates are used to treat diseases of the liver and lungs caused by excessive and progressive tissue scarring, called fibrosis. Pacific Therapeutics was founded by Douglas H. Unwin on September 12, 2005 and is headquartered in Vancouver, Canada. | 10 years |
| J. Basil Peters | M | - |
University of British Columbia
| 8 years |
| Paul Bowes | M | - |
University of British Columbia
| 4 years |
| Ronald Tysoe | M | 71 |
University of British Columbia
| 5 years |
| Dale A. Rondeau | M | 69 |
University of Saskatchewan
| 7 years |
| Gregg Saretsky | M | 64 |
University of British Columbia
| 6 years |
| Ralph D. McRae | M | - |
University of British Columbia
| 5 years |
| Jerry A. Olynuk | M | - |
University of Saskatchewan
| 7 years |
| S. Simpson | M | 67 |
University of British Columbia
| 7 years |
| P. Reifel | M | 72 |
University of British Columbia
| 6 years |
| Donald George Burrell | M | 69 |
University of British Columbia
| 5 years |
| John Buckle | M | - | 3 years | |
| Noralee Bradley | F | - |
University of Saskatchewan
| - |
| Gregory Burnett | M | - |
University of British Columbia
| 6 years |
| Shelley Tratch | F | - |
University of British Columbia
| 6 years |
| Robert McKnight | M | 74 | 4 years | |
| Steven Nizam Khan | M | - |
University of British Columbia
| 7 years |
| Timothy Delaney | M | 69 |
University of British Columbia
| 4 years |
| Pierre Zakaruaskas | M | 63 |
University of British Columbia
| 3 years |
| Tom Salisbury | M | - |
University of British Columbia
| 3 years |
| Graham Heal | M | 63 |
University of British Columbia
| 4 years |
| Howie Young | M | - |
University of British Columbia
| 4 years |
| Perry Grunenberg | M | 65 |
University of British Columbia
| 4 years |
| Tim Louis | M | 65 |
University of British Columbia
| 4 years |
| Aerock Fox | M | 77 |
University of British Columbia
| 3 years |
| Barry Loughlin | M | 64 |
University of British Columbia
| 4 years |
| Steven Cook | M | 69 |
University of British Columbia
| 4 years |
| Kenneth Konkin | M | - |
University of British Columbia
| 4 years |
| Greg Tedesco | M | - |
University of British Columbia
| 4 years |
| Fred Withers | M | - |
University of British Columbia
| 4 years |
| David Christie | M | 77 |
University of British Columbia
| 4 years |
| Douglas Buchanan | M | - |
University of British Columbia
| 3 years |
| Stuart Shelley | M | - |
University of British Columbia
| 4 years |
| Dae-Ryun Jang | M | 67 |
University of British Columbia
| 4 years |
| John Robins | M | 64 |
University of British Columbia
| 4 years |
| Mark Feldinger | M | - |
University of British Columbia
| 4 years |
| Ronald Ewing | M | - |
University of British Columbia
| 4 years |
| Colin Harris | M | 66 |
University of British Columbia
| 5 years |
| James Stewart | M | 65 |
University of British Columbia
| 3 years |
| Gregory D. Aasen | M | 68 |
University of British Columbia
| 4 years |
| Ross Beaty | M | 72 |
University of British Columbia
| 3 years |
| Eric H. Carlson | M | - |
University of British Columbia
| 4 years |
| Dave Jiles | M | - |
University of British Columbia
| 4 years |
| J. Seppala | M | - |
University of British Columbia
| 3 years |
| Thomas Turner | M | 67 |
University of British Columbia
| 4 years |
| Michael Pedersen | M | 63 |
University of British Columbia
| 4 years |
| Robert George Lewis | M | - |
University of British Columbia
| 3 years |
| Andrew William Gourlay | M | - |
University of British Columbia
| 4 years |
| Keith Spencer | M | 65 |
University of British Columbia
| 3 years |
| Kim M. Phillips | M | - |
University of British Columbia
| 4 years |
| Alan Strachan | M | - |
University of British Columbia
| 4 years |
| Martin Gleave | M | 65 |
University of British Columbia
| 3 years |
| Alex Marazzi | M | - |
University of British Columbia
| 4 years |
| David Lyall | M | 68 |
University of British Columbia
| 4 years |
| Doug Eaton | M | - |
University of British Columbia
| 4 years |
| Andrew Arthur | M | 62 |
University of British Columbia
| 4 years |
| Lam Sin Lai Tsui | M | 69 |
University of British Columbia
| 4 years |
| Robert Waters | M | 73 |
University of British Columbia
| 4 years |
| James Hutton | M | 63 |
University of British Columbia
| 4 years |
| Ching Har Chan | M | 67 |
University of British Columbia
| 4 years |
| Murray Munro | M | - |
University of British Columbia
| 4 years |
| Jeffrey B. Austin | M | - |
University of British Columbia
| 4 years |
| Robert C. van Walleghem | M | - |
University of British Columbia
| 4 years |
| Matthew Kavanagh | M | 68 |
University of British Columbia
| 4 years |
| Peter M. Holbek | M | - |
University of British Columbia
| 6 years |
| Peter Virvilis | M | - |
University of British Columbia
| 4 years |
| Deborah E. Fortescue-Merrin | F | 68 |
University of British Columbia
| 4 years |
| John D. Hilland | M | 68 |
University of British Columbia
| 4 years |
| Kim Yum Chan | F | 65 |
University of British Columbia
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Canada | 99 | 99.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Douglas Unwin
- Personal Network